First Citizens Bank & Trust’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
First Citizens Bank & Trust's CRL Position: Q2 2022 in Review
First Citizens Bank & Trust sold out of Charles River Laboratories (CRL) in Q2 2022, closing a stake of 1,478 shares — an estimated $420K sold.
First Citizens Bank & Trust first reported a position in CRL in Q3 2013 and held it in 12 quarters. The position peaked at $676K in Q3 2021. 627 funds tracked by Wall St. Rank hold CRL as of Q2 2022.
- First Citizens Bank & Trust reported no remaining Charles River Laboratories position as of Q2 2022 after selling out during the quarter.
- First Citizens Bank & Trust sold 1,478 Charles River Laboratories shares in Q2 2022, an estimated $420K.
- First Citizens Bank & Trust first reported a position in Charles River Laboratories in Q3 2013 and held it in 12 quarters.
- First Citizens Bank & Trust's Charles River Laboratories position peaked at $676K in Q3 2021.
- 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2022.
Based on First Citizens Bank & Trust's 13F filing for Q2 2022, filed 26 Jul 2022.